Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 9/20 | 0.46 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.37 |
| ▸ | SGK1 | O00141 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.36 |
| ▸ | USP2 | O75604 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.36 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.36 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | BPTF | Q12830 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL4663967 | 0.92 | NR1I2 (0.40) | NR1I2TGFBR1CYP1A2CYP2C9CLK4 | |
| Formic Acid SCHEMBL4664322 | 0.92 | NR1I2 (0.37) | NR1I2TGFBR1CYP1A2CYP2C9CLK4 | |
| SCHEMBL4666064 | 0.85 | CYP1A2 (0.37) | NR1I2TGFBR1CYP1A2CYP2C9CLK4 | |
| SCHEMBL4666058 | 0.85 | BPTF (0.52) | NR1I2BPTF | |
| Formic Acid SCHEMBL4665678 | 0.84 | HTT (0.41) | NR1I2PTPN2PTPN1PTPN5MAPT | |
| Formic Acid SCHEMBL4663920 | 0.83 | HTR6 (0.46) | NR1I2SGK1BPTF | |
| Formic Acid SCHEMBL4663834 | 0.82 | JAK1 (0.40) | SGK1CYP1A2CYP2C9CLK4USP2 | |
| Formic Acid SCHEMBL4664281 | 0.81 | HTR6 (0.46) | NR1I2SGK1BPTF | |
| SCHEMBL4663971 | 0.81 | MAPK1 (0.37) | NR1I2TGFBR1CYP1A2CYP2C9CLK4 | |
| Formic Acid SCHEMBL4664240 | 0.80 | HTR6 (0.51) | NR1I2SGK1CYP1A2CYP2C9CLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080242681-A1 | N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors | ALTANA PHARMA AG (DE) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242681-A1 | N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors | MAP3K19, MAP3K6, MAP3K20 | NR1I2 1040/4885TGFBR1 1515/4885SGK1 777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.